Apricity Therapeutics SBIR Phase I Award, September 2020
A SBIR Phase I contract was awarded to Apricity Therapeutics in September, 2020 for $168,000.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.
Is a
Award Amount (USD)
168,000
0
Government Branch
Date Awarded
September 1, 2020
0
End Date
August 31, 2021
0
SBIR/STTR Award Recipient
Contract Number (US Government)
1R43FD006909-01
0
Award Phase
Phase I
0
Award Type
SBIR
0
Official Website
Find more entities like Apricity Therapeutics SBIR Phase I Award, September 2020
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.